AI Governance · Healthcare & Life Sciences
Healthcare AI governance in 2026: who holds the liability when the AI is wrong?

Direct Answer
In 2026, liability for AI-influenced clinical decisions is shifting onto health systems and the individual clinicians who sign the note. As the FDA loosened oversight of clinical decision support software and the HHS Office for Civil Rights began penalizing documented-but-unremediated risk, the exposure that regulators and vendors once absorbed now defaults to the hospital that deployed the tool and the clinician who acted on it. Most health systems have never consciously decided who is accountable. By staying silent, they have chosen the clinician.
The comfortable assumption is that AI governance is a compliance exercise you can schedule for next quarter. It is not. For two decades, healthcare security optimized for a perimeter: known systems, known vendors, known data flows. That world is gone. The defining risk of 2026 is not the external attacker hitting a known system. It is invisible internal adoption moving faster than governance can inventory it.
89%
Drop in unauthorized AI use when sanctioned tools are provisioned
~66%
Epic hospitals that have adopted ambient AI scribes
~25%
Healthcare orgs with a formal AI governance framework
Why healthcare AI governance became a CISO problem overnight
The scale is no longer a rounding error. In large enterprises, an estimated 30 to 40 percent of IT spend now runs through shadow IT outside official oversight. Layer generative AI on top and the gap widens. IBM found that more than 60 percent of organizations have no governance policy to manage AI or detect its unsanctioned use. In healthcare that blind spot is uniquely dangerous, because the same lack of visibility that hides a data leak also hides an unvalidated tool influencing patient care.
The result: only about a quarter of healthcare organizations have a formal AI governance framework in place, even as the large majority plan to expand AI use. That gap has landed on the CISO's desk, and it arrived faster than the org chart was ready for.
What is shadow AI in healthcare?
Shadow AI in healthcare is the use of AI tools, including chatbots, ambient scribes, and autonomous agents, without the knowledge, approval, or security review of the IT and compliance teams responsible for protecting patient data.
It usually is not malicious. It is a burnout response. Clinicians facing one to two hours of documentation for every hour of patient care reach for any tool that promises relief, and the friction of generative AI is nearly zero. The problem is visibility. When security teams do not know which AI tools are in use, they cannot assess risk, enforce policy, or establish accountability.
The most important finding for healthcare leaders is the shape of the solution, not the size of the problem. Cloud Security Alliance research found that when organizations provision sanctioned AI tools, unauthorized use drops by 89 percent. You do not police your way out of shadow AI. You provision your way out of it, then govern what you provisioned.
The sanctioned ambient scribe is the bigger blind spot
Shadow AI gets the headlines, but the more dangerous exposure often wears a badge. Ambient AI scribes, the tools that record the patient encounter and draft the clinical note, are now near-ubiquitous, with roughly two-thirds of hospitals on Epic having adopted them.
Here is the governance trap. These tools were approved once, at procurement, against a model version that has since been updated quietly by the vendor, often with limited transparency. The thing you validated is not the thing running today. Deploying an ambient scribe can itself require updating your security risk analysis, access controls, and retention policies, and key vendor-diligence questions frequently go unasked:
- Is our patient data used to train the vendor's models?
- What happens to our ePHI if we terminate the contract?
- Is audio retained, and for how long?
- Has the tool been re-validated since the last model update?
A subtle technical trap hides under the comfortable answer "it is de-identified." Modern AI systems can re-identify data even after PHI is removed. The question no standard review asks is the one that matters most: when did you last re-validate the AI you already trust?
Who is liable for AI decisions in healthcare?
When an AI-influenced decision harms a patient, liability defaults to two parties: the institution that deployed the tool and the individual clinician who acted on it. Three regulatory shifts in 2026 converged to create this.
The FDA stepped back. Revised guidance loosened oversight of clinical decision support software a clinician can independently review. Less oversight does not reduce risk. It relocates it onto the health system.
OCR stepped forward. Enforcement expanded from risk analysis to risk management. You must now prove you acted on identified risks. A documented risk you never remediated is no longer a shield. It is a dated admission that you knew about a danger and left it open.
Clinical accountability never shifts. The signing clinician remains responsible for the note's accuracy and the decision's soundness, cast as the "human oversight" in a system that may never have made its reasoning reviewable.
Most health systems have not decided who holds this liability on purpose. And if you have not decided, you have decided. You chose the clinician, by silence.
Compliance is not the same as patient safety
A fully HIPAA-compliant AI deployment can still harm a patient, and a model validated "on average" can be quietly unsafe for the subpopulation it barely saw in training. Optimizing a governance program for audit-readiness instead of patient safety is not a clever shortcut. It is the kind of sophisticated negligence that does not survive discovery once a patient is harmed.
The most clarifying governance question in medicine appears on no compliance checklist: would you let this AI make a call on your own family's care? When the honest answer and the official deployment decision diverge, that gap is the precise location of your unmanaged risk.
What is the best AI governance framework for hospitals?
There is no single standard. Defensible healthcare AI governance layers several frameworks together:
- NIST Cybersecurity Framework (CSF 2.0). The security and HIPAA foundation, extended to AI assets.
- NIST AI Risk Management Framework. Govern, Map, Measure, Manage: the functions that address what CSF cannot, including bias, explainability, and model drift.
- ISO/IEC 42001. Run the AI RMF as your operating framework and treat ISO 42001 as the audit-readiness and certification target.
- Healthcare overlays. The HHS, ASPR, and NIST HPH Implementation Guide, FDA Section 524B controls for device-grade AI, and the HSCC third-party AI supply-chain guide.
A framework is scaffolding, not the building. The artifact everything depends on is the AI inventory: a classified register where every AI system carries a clinical or operational purpose, its PHI involvement, a risk tier, a named accountable owner, and lifecycle status. The Cloud Security Alliance frames inventory gaps as the primary governance metric, owned the way a CISO already owns the vulnerability inventory.
A 90-day healthcare AI governance action plan
- Decide accountability explicitly. Get legal, clinical leadership, risk, and the board to assign, in writing, who owns the consequences of an AI-influenced decision.
- Build and tier the AI inventory. You cannot govern, re-validate, or defend what you have not inventoried.
- Provision, do not just block. Give clinicians sanctioned, governed tools, the 89 percent lever, paired with a no-blame disclosure path.
- Re-validate what you already approved. Start with the ambient scribe.
- Convert the risk register into a remediation ledger. Owner, date, and closure evidence for every risk.
- Govern AI agents as first-class identities. Least-privilege scope, employee-style offboarding, machine-readable policy.
The bottom line
The regulators have repriced the risk and quietly handed health systems the bill. The vendors have accelerated. Clinicians are already using the tools. The only open variable is whether your institution decides who holds the liability deliberately, now, or by accident, later, in front of a jury. That decision is governance work, not security tooling.
Optional Download · Position Paper
Who Holds the Bag?
The full Sophizo position paper for hospital security, compliance, and clinical-informatics leaders. A 15-minute read on shadow IT, shadow AI, and the quiet relocation of liability onto your health system.
- The three 2026 regulatory shifts that moved the liability, and the two parties it now lands on.
- The 89 percent provisioning lever, and the AI inventory artifact every defensible program depends on.
- The ambient-scribe re-validation trap, and the vendor-diligence questions most teams never ask.
- A 90-day healthcare AI governance action plan you can take to the board.
Send me the paper.
Tell us where to send it. Opens instantly in a new tab.
FAQ
Is shadow AI a HIPAA violation?
It can be. When clinicians enter protected health information into consumer AI tools without a Business Associate Agreement, it creates a HIPAA exposure. The EHR vendor's BAA does not automatically cover the AI layer built on top of it, so many of these gaps go unmapped until an incident forces them into view.
Does the FDA regulate AI clinical decision support?
As of January 2026, the FDA loosened oversight of clinical decision support software a clinician can independently review, moving it outside device oversight. It kept oversight of higher-risk uses and image-analysis tools. Reduced FDA oversight does not remove the risk. It shifts the governance and liability burden onto the health system that deploys the tool.
Who is responsible when an AI medical scribe makes an error?
Clinical accountability does not shift to the vendor. The signing clinician remains responsible for the accuracy and completeness of the note. That is why human review, re-validation after model updates, and clear governance policy are essential rather than optional.
How do you reduce shadow AI in healthcare?
You provision your way out of it rather than policing your way out of it. Cloud Security Alliance research found that when organizations provision sanctioned AI tools, unauthorized use drops by 89 percent. Give clinicians a safe, governed path, pair it with a no-blame disclosure channel, then govern what you provisioned.
What framework should hospitals use for AI governance?
Most defensible programs layer NIST CSF 2.0, the NIST AI Risk Management Framework, and ISO/IEC 42001, with healthcare-specific overlays from HHS and the HSCC. The anchor artifact is a complete, risk-tiered AI inventory where every system carries a purpose, its PHI involvement, a risk tier, and a named accountable owner.
Sources
- U.S. Food and Drug Administration, revised guidance on clinical decision support software, January 2026.
- HHS Office for Civil Rights, HIPAA Security Rule enforcement posture, risk analysis to risk management, 2026.
- IBM, organizational AI governance readiness research, 2025.
- Cloud Security Alliance, research on sanctioned AI provisioning and the 89 percent reduction in unauthorized use, 2025 to 2026.
- Gartner, projections on enterprise AI agent proliferation, 2025.
- U.S. Department of Veterans Affairs Office of Inspector General, review of ambient AI scribe classification, 2026.
- NIST, "Cybersecurity Framework (CSF) 2.0," February 2024, and "AI Risk Management Framework (AI RMF 1.0)," January 2023.
- ISO/IEC 42001:2023, "Information technology, Artificial intelligence, Management system," December 2023.
- Health Sector Coordinating Council, third-party AI supply-chain guidance, 2025.
Decide it on purpose
Name the accountable owner before a plaintiff's attorney does.
Sophizo builds the governance architecture your AI runs on: the AI inventory, decision rights, re-validation cadence, and defensible evidence. We diagnose the gap between what your organization can prove and what it has actually validated, then close it.
Related resources
Keep exploring the frameworks and engagements connected to this topic.
AI Governance
Board-grade controls and risk taxonomy.
AI Regulations
The regulatory map behind the controls.
NIST AI RMF for Small Business
The risk framework scaled to lean teams.
EU AI Act Classification Checklist
Classify your B2B SaaS system correctly.
Governance Accelerator
Compressed board-grade governance buildout.